Tulane Urology
Residency & Fellowship Program


 
 

Cancer Studies

If you are interested in being a subject in any of these open studies, please contact Sara Jamison, LPN. (504-988-2162)

SWOG #9346, Prostate Cancer, newly diagnosed stage D2. Intermittent Androgen Deprivation versus Continuous Androgen Deprivation after 8 months induction therapy and normalization of PSA. Phase III. Open TMC, VA, MCLNO. RX supplied.

SWOG #9921, Prostate Cancer, Post-Op Stage T1-2, Adjuvant Androgen Deprivation versus Androgen Deprivation plus Mitoxantrone and Prednisone in high risk patients following Radical Prostatectomy. Phase III. Open TMC, VA. GCRC pending. RX supplied.


Department of Urology  |  Tulane School of Medicine   |  Tulane University

Tulane University  ·  Department of Urology  ·  SL-42 ·  New Orleans, LA 70112
Office Phone: 504-988-2750  ·  Fax: 504-988-5059  ·  Email: urology@tulane.edu